My dr. wants me to join the Natalee trial which is based on the success of the Monaleesa trial for women with Stage 4 breast cancer. the drug is Kisqali (ribociclib) tablets. It was administered in 6 mg tablets for the Monaleesa trial and will be given in 4 mg for the Natalee trial. The problem I am having with it is the large percentage of side effects for the women in the Monaleesa trial. I am stage two, two nodes involved, and two unifocal tumors in the right breast. I just don't know if the benefits outweigh the risks. I did surgery, then chemo for 4 cycles, and i am going to start radiation for 7 weeks, followed by an aromatase inhibitor. If this treatment lowers my chances of recurrence to 10%? what am I really gaining other than more side effects? The purpose of the study is to see if this medication will work on lowering recurrance rate to women with early stage breast cancer.
I know that there are a lot of you out there pretty savy with research, so I would really appreciate your input.
thank you soooo much.